202 related articles for article (PubMed ID: 15784653)
21. Protosappanin a, an immunosuppressive constituent from a Chinese herb, prolongs graft survival and attenuates acute rejection in rat heart allografts.
Wu J; Hou JB; Zhang MM; Zou YP; Yu B
Transplant Proc; 2008 Dec; 40(10):3719-22. PubMed ID: 19100473
[TBL] [Abstract][Full Text] [Related]
22. New evidence for a role of allograft accommodation in long-term tolerance.
Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
[TBL] [Abstract][Full Text] [Related]
23. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
[TBL] [Abstract][Full Text] [Related]
24. Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury.
Genovese T; Mazzon E; Esposito E; Di Paola R; Murthy K; Neville L; Bramanti P; Cuzzocrea S
Free Radic Res; 2009 Jul; 43(7):631-45. PubMed ID: 19418318
[TBL] [Abstract][Full Text] [Related]
25. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
27. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
29. Utility of adenovirus-mediated Fas ligand and bcl-2 gene transfer to modulate rat liver allograft survival.
Wang DS; Li Y; Dou KF; Li KZ; Song ZS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):505-10. PubMed ID: 17085333
[TBL] [Abstract][Full Text] [Related]
30. Protein tyrosine nitration and poly(ADP-ribose) polymerase activation in N-methyl-N-nitro-N-nitrosoguanidine-treated thymocytes: implication for cytotoxicity.
Bai P; Hegedus C; Erdélyi K; Szabó E; Bakondi E; Gergely S; Szabó C; Virág L
Toxicol Lett; 2007 May; 170(3):203-13. PubMed ID: 17428624
[TBL] [Abstract][Full Text] [Related]
31. Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate.
Schwartz CF; Kilgore KS; Homeister JW; Levy BA; Lucchesi BR; Bolling SF
J Surg Res; 1999 Sep; 86(1):24-8. PubMed ID: 10452864
[TBL] [Abstract][Full Text] [Related]
32. Phase-directed therapy and cardiac xenograft survival.
Lin H; Gastman BR; Wei RQ; Kunkel SL; Gordon D; Bolling SF
J Surg Res; 1997 Sep; 72(1):84-8. PubMed ID: 9344718
[TBL] [Abstract][Full Text] [Related]
33. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
[TBL] [Abstract][Full Text] [Related]
34. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
Dudler J; Simeoni E; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
Transpl Int; 2007 May; 20(5):460-6. PubMed ID: 17313449
[TBL] [Abstract][Full Text] [Related]
35. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
[TBL] [Abstract][Full Text] [Related]
37. Tetrahydrobiopterin compounds prolong allograft survival independently of their effect on nitric oxide synthase activity.
Brandacher G; Maglione M; Schneeberger S; Obrist P; Thoeni G; Wrulich OA; Werner-Felmayer G; Margreiter R; Werner ER
Transplantation; 2006 Feb; 81(4):583-9. PubMed ID: 16495807
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer.
Tange S; Scherer MN; Graeb C; Andrassy J; Justl M; Frank E; Jauch KW; Geissler EK
Transpl Int; 2003 Jul; 16(7):471-5. PubMed ID: 12677363
[TBL] [Abstract][Full Text] [Related]
39. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
Arora M; Kumar A; Kaundal RK; Sharma SS
Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
Fleury S; Li J; Simeoni E; Fiorini E; von Segesser LK; Kappenberger L; Vassalli G
Gene Ther; 2006 Jul; 13(14):1104-9. PubMed ID: 16541117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
